131 related articles for article (PubMed ID: 35347995)
1. Redox-Responsive Disulfide Cyclic Peptides: A New Strategy for siRNA Delivery.
Mandal D; Mohammed EHM; Lohan S; Mandipoor P; Baradaran D; Tiwari RK; Parang K; Aliabadi HM
Mol Pharm; 2022 May; 19(5):1338-1355. PubMed ID: 35347995
[TBL] [Abstract][Full Text] [Related]
2. Construction and Biological Evaluation of a Novel Integrin α
Chen X; Liu M; Wang R; Yan P; Zhang C; Ma C; Yin L
Molecules; 2017 Feb; 22(2):. PubMed ID: 28165399
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells.
Zhang C; Yuan W; Wu Y; Wan X; Gong Y
Life Sci; 2021 Feb; 266():118886. PubMed ID: 33310044
[TBL] [Abstract][Full Text] [Related]
4. Peptide/Lipid-Associated Nucleic Acids (PLANAs) as a Multicomponent siRNA Delivery System.
Hall R; Alasmari A; Mozaffari S; Mahdipoor P; Parang K; Montazeri Aliabadi H
Mol Pharm; 2021 Mar; 18(3):986-1002. PubMed ID: 33496597
[TBL] [Abstract][Full Text] [Related]
5. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
Chen G; Wang Y; Xie R; Gong S
J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Application of Peptide-siRNA Nanoparticles from Disulfide-Constrained Cyclic Amphipathic Peptides for the Functional Delivery of Therapeutic Oligonucleotides to the Lung.
Welch JJ; Dean DA; Nilsson BL
Methods Mol Biol; 2021; 2208():49-67. PubMed ID: 32856255
[TBL] [Abstract][Full Text] [Related]
7. Impact of Peptide Sequence on Functional siRNA Delivery and Gene Knockdown with Cyclic Amphipathic Peptide Delivery Agents.
Jagrosse ML; Baliga UK; Jones CW; Russell JJ; García CI; Najar RA; Rahman A; Dean DA; Nilsson BL
Mol Pharm; 2023 Dec; 20(12):6090-6103. PubMed ID: 37963105
[TBL] [Abstract][Full Text] [Related]
8. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
[TBL] [Abstract][Full Text] [Related]
9. Redox-responsive, reversibly-crosslinked thiolated cationic helical polypeptides for efficient siRNA encapsulation and delivery.
Zheng N; Song Z; Liu Y; Zhang R; Zhang R; Yao C; Uckun FM; Yin L; Cheng J
J Control Release; 2015 May; 205():231-9. PubMed ID: 25683619
[TBL] [Abstract][Full Text] [Related]
10. A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells.
Li G; Hu Z; Yin H; Zhang Y; Huang X; Wang S; Li W
Int J Nanomedicine; 2013; 8():1293-306. PubMed ID: 23569377
[TBL] [Abstract][Full Text] [Related]
11. Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovarian Cancer Cell Lines.
Mandal D; Lohan S; Sajid MI; Alhazza A; Tiwari RK; Parang K; Montazeri Aliabadi H
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839988
[TBL] [Abstract][Full Text] [Related]
12. Cyclic peptide-based nanostructures as efficient siRNA carriers.
Panigrahi B; Singh RK; Mishra S; Mandal D
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S763-S773. PubMed ID: 30311806
[TBL] [Abstract][Full Text] [Related]
13. Cationic liposome decorated with cyclic RGD peptide for targeted delivery of anti-STAT3 siRNA to melanoma cancer cells.
Khabazian E; Vakhshiteh F; Norouzi P; Fatahi Y; Dinarvand R; Atyabi F
J Drug Target; 2022 Jun; 30(5):522-533. PubMed ID: 34482780
[TBL] [Abstract][Full Text] [Related]
14. Tumor-targeted delivery of siRNA using fatty acyl-CGKRK peptide conjugates.
Sharma M; El-Sayed NS; Do H; Parang K; Tiwari RK; Aliabadi HM
Sci Rep; 2017 Jul; 7(1):6093. PubMed ID: 28733622
[TBL] [Abstract][Full Text] [Related]
15. Humanized Lewis-Y specific antibody based delivery of STAT3 siRNA.
Ma Y; Kowolik CM; Swiderski PM; Kortylewski M; Yu H; Horne DA; Jove R; Caballero OL; Simpson AJ; Lee FT; Pillay V; Scott AM
ACS Chem Biol; 2011 Sep; 6(9):962-70. PubMed ID: 21766840
[TBL] [Abstract][Full Text] [Related]
16. A systematic comparison of lipopolymers for siRNA delivery to multiple breast cancer cell lines: In vitro studies.
Aliabadi HM; Bahadur K C R; Bousoik E; Hall R; Barbarino A; Thapa B; Coyle M; Mahdipoor P; Uludağ H
Acta Biomater; 2020 Jan; 102():351-366. PubMed ID: 31760224
[TBL] [Abstract][Full Text] [Related]
17.
Wan X; Sun R; Bao Y; Zhang C; Wu Y; Gong Y
Mol Pharm; 2021 Nov; 18(11):3990-3998. PubMed ID: 34591491
[TBL] [Abstract][Full Text] [Related]
18. Delivery of gene targeting siRNAs to breast cancer cells using a multifunctional peptide complex that promotes both targeted delivery and endosomal release.
Bjorge JD; Pang A; Fujita DJ
PLoS One; 2017; 12(6):e0180578. PubMed ID: 28666009
[TBL] [Abstract][Full Text] [Related]
19. Engineered Histidine-Enriched Facial Lipopeptides for Enhanced Intracellular Delivery of Functional siRNA to Triple Negative Breast Cancer Cells.
Biswas A; Chakraborty K; Dutta C; Mukherjee S; Gayen P; Jan S; Mallick AM; Bhattacharyya D; Sinha Roy R
ACS Appl Mater Interfaces; 2019 Feb; 11(5):4719-4736. PubMed ID: 30628773
[TBL] [Abstract][Full Text] [Related]
20. Amphiphilic Peptides for Efficient siRNA Delivery.
Mozaffari S; Bousoik E; Amirrad F; Lamboy R; Coyle M; Hall R; Alasmari A; Mahdipoor P; Parang K; Montazeri Aliabadi H
Polymers (Basel); 2019 Apr; 11(4):. PubMed ID: 30999603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
